FECS-DF (S. Biomedics)

N/A

Report date: 2025/05/20 20:00:09

Base Information

Drug NameFECS-DF (S. Biomedics)

Drug Alias NameFECSDF - Clusters of Autologous Dermal Fibroblasts3D-FFECSDFFECS DF

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapy

Mechanisms of ActionCell replacements

TargetsUpdating

Therapy Area/IndicationsNasolabial fold wrinkles

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesS.Biomedics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesS.Biomedics Co Ltd

Inactive CompaniesN/A

Active IndicationsNasolabial fold wrinkles

Inactive IndicationsN/A

Other Information

ATC CodeN/A